chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Heart started racing rapidly; Felt dizzy; Eyes felt like swelling; Still feeling bad since the shot; Could not catch her breath; A spontaneous report (United States) was received from a consumer concerning herself, a  64-year-old patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced rapid racing of her heart / palpitation, felt dizzy, eyes felt like swelling, could not catch her breath / dysnopea and was still feeling bad since the shot / feeling abnormal.  The patient's medical history was not reported. Concomitant medications reported included thyroid medications, Escitalopram oxalate, Pravastatin, Trazodone and vitamins.  On 21 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 042L20A) in the arm for prophylaxis of COVID-19 infection. The route of administration was not provided.  On 21 Jan 2021, as soon as she was injected her heart started racing rapidly, felt dizzy, her eyes felt like swelling and she could not catch her breath. A nurse at the facility spoke to her and calmed her down but she was still feeling bad since the shot.  Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events, heart started racing rapidly, felt dizzy, her eyes felt like swelling and she could not catch her breath resolved on 21 Jan 2021.  The outcome of the event, feeling bad since the shot was not resolved at the time of report.
WEAKNESS AND SLURRED SPEECH Narrative:  SPOUSE STATES PATIENT HAD WEAKNESS AND SLURRED SPEACH AND HAD TO BE HELPED TO THE BATHROOM MORNING OF 2/11/2021. THE SYMPTOMS RESOLVED BY THE EVENING OF 2/11/2021
Bell?s palsy , prescribed prednisone and Valtrex Prognosis: should start to clear up in 2 weeks
"whole body hurting", polyarthralgias, eventually developing a polyarthritis involving multiple large and small joints, with visible swelling of the fingers and left wrist. No response to date from NSAID meds; improved on prednisone, relapsed when prednisone stopped. Now considering methotrexate after 5 weeks of symptoms.  Too soon to say anything about long-term prognosis, so I cannot complete the section below.
This spontaneous report as received from the patient's mother refers to her 5 month old daughter with no pertinent medical history and no drug reactions/allergies. On 26-JUN-2013 the patient was vaccinated with the first dose of ROTATEQ (dose, frequency, route and lot# not reported) at her 17 weeks which was outside of the prescribing information. The patient had experienced a lot of gas since receiving the shot on 26-JUN-2013. The patient did not seek medical attention but was given some unspecified gas drops. No lab diagnostics studies were performed. The patient had not recovered. Additional information is not expected.
Tinnitus doubled in volume, digestive system shut down, bladder function shut down, COPD increased severly (very short of breath), weakness in use of legs, increase in pain from neuropathy of legs and hands, arthritis began in neck and both arms.
My neck is bothering; I was nauseas; had a little but of a sinus headache; This is a spontaneous report received from a Pfizer sponsored program Pfizer RXPathways from a contactable consumer. A patient of unspecified age and gender received first dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. Patient had the covid vaccine two weeks before and was going for second dose in a week. Patient's neck was bothering at the time of the report and wanted to take ibuprofen(ADVIL) or paracetamol(TYLENOL). The patient's question was number one could she or he take it and number two was it going to change the efficacy of the vaccine. Patient slept the wrong way, patient knew exactly what happened, he or she fell asleep with the TV on. Patient just want to take something to alleviate that, its her or his shoulder somewhere around there. Patient just slept the wrong way, he or she knew it when woke up. As far as the vaccine the patient was good with that. Patient took it with no reaction, second day patient was nauseas and had a little but of a sinus headache, drank a can of soda and a little grits and patient was fine and been fine since. The outcome of the events was unknown.    Information on the lot/batch number has been requested.
Almost immediately after MMR given in R triceps area there was moderate swelling limited to the entire R arm.
This spontaneous report as received from a 35 year old female pharmacy student regarding herself. No medical history and concurrent conditions were reported. On an unknown date approximately in September 2015 (also reported as 2 months ago) the patient was vaccinated with GARDASIL dose 4 (Extra dose administered) (lot number and expiry date unknown) (dosing regimen and frequency unknown). No concomitant medications were reported. No adverse effects were reported. The action taken with the therapy with GARDASIL was unknown. The outcome of the events was unknown. There was no product quality complaint reported. Additional information has been requested.
This case was reported by a pharmacist via call center representative and described the occurrence of Injection site swelling in a 62-year-old adult female patient who received SHINGRIX (batch number ZN22Z, expiry date 2nd February 2021) for prophylaxis. On an unknown date, the patient received SHINGRIX (subcutaneous). On an unknown date, unknown after receiving SHINGRIX, the patient experienced intramuscular formulation administered by other route. On an unknown date, the outcome of the intramuscular formulation administered by other route was unknown. Additional details were provided as follows: The healthcare professional reported that the patient received a dose of SHINGRIX subcutaneously, which led to incorrect route of vaccine administration. This case has been linked with US2018126944, reported by same reporter. Follow up information was received from a pharmacist on 8th August 2018: The patient's demographic details was updated. On 11th July 2018, the patient received 1st dose of 0.5 ml SHINGRIX. The error occurred during administration. It was administered subcutaneously where it meant to be injected intramuscularly. The patient reported days later that the injection site became swollen or red and painful. The reporter stated that they followed through with the patient and the patient stated the symptoms went away in a week. The patient was advised to return for a second dose in 2 to 6 months. The VAERS details were updated. This was medication error associated with adverse events.
sore arm; Little bit fever/ Fever 100.4 degree temperature; Shivers; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), PYREXIA (Little bit fever/ Fever 100.4 degree temperature) and CHILLS (Shivers) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high and Chronic obstructive pulmonary disease.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Mar-2021, the patient experienced CHILLS (Shivers). On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm) and PYREXIA (Little bit fever/ Fever 100.4 degree temperature). At the time of the report, PAIN IN EXTREMITY (sore arm), PYREXIA (Little bit fever/ Fever 100.4 degree temperature) and CHILLS (Shivers) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.    This case was linked to MOD-2021-066333 (Patient Link).
her daughter, 13 started her first period ever 3 days after her first shot and did not have another period for 6 months; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 13 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm (Batch/Lot number: unknown) at the age of 13 years as dose 1, single and intramuscular (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: MENSTRUATION IRREGULAR (non-serious), outcome "unknown", described as "her daughter, 13 started her first period ever 3 days after her first shot and did not have another period for 6 months". Additional information: Mensuration started within 48 hours of her first two vaccine doses even though her cycle was due 10-15 days later. That was unusual for her. Additionally, her daughter, 13 started her first period ever 3 days after her first shot and did not have another period for 6 months. She reported mensural cramps again after her third 1 day after her booster shot but had not started menstruating at the time of our discussion. No covid prior vaccination. covid was tested post vaccination. Patient got Pfizer/BioNTech vaccine and started first period days after the injection. Mom doesn't remember if it was first or second shot. Didn't have another period for 6 months. Mom and sister started period 2 years later in age than patient. No other adverse events.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
With the first dose she felt the little warmth or gush of the medication going in; This is a spontaneous report from a contactable consumer (patient). A 71-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3246), via an unspecified route of administration at the upper left arm on 06Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. With the first dose she felt the little warmth or gush of the medication going in on 06Jan2021, not pain but she could feel it going in but with this second shot there was nothing and no blood. The outcome of the event was unknown.
5cm local reaction at site of Tdap in (L) arm. Give BENADRYL.
About 5 minutes AFTER RECIEVING THE PFIZER VACCINE 1ST DOSE, THE PATIENT STARTED TO SWEAT, FELT DIZZY AS HE SAT IN HIS CHAIR & PASSED OUT FOR 5-10 SECONDS... CAME BACK GAIN CONSCIENCE AS THE PERSON NEAR BY TAP HIM HIS SHOULDER & ASK IF HE WAS OK. SHE CAME TO GET ME & I GAVE THE PATIENT SOME WATER TO SIP A LITTLE WATER. HE SAID HE FEELS BETTER THAT HE'S OK, HAD NO SHORTNESS OF BREATH. I TOLD HIM I WILL CHECK ON HIM IN A FEW MINUTES AGAIN.  A FEW MINUTES LATER, HE DECIDED TO GET UP SUDDENLY  FELL TO THE FLOOR. 911 WAS CALLED & FRONT STORE SUPERVISER & I MONITOR UNTIL AMBULANCE CAME FOR HIM. PT JUST FELT WEAK, BUT O SHORTNESS OR BREATH . I HAD THE PATIENT STAYED LYING DOWN ON ONE SIDE, SO AIRWAY IS NOT BLOCKED. A CUSTOMER HELP TALK TO HIM TO MAKE SURE HE STAY CONSCIENCE UNTIL AMBULNACE ARRIVED & TOOK OVER.
This spontaneous report was received from a registered nurse, concerning a non-pregnant 17 year old female patient. The patient did not have medical history, concurrent conditions, drug reactions or allergies. Her concomitant medications included an unspecified birth control method. On 04-JAN-2017, 19-JUN-2017 and 24-JAN-2018, the patient received doses of GARDASIL 9 (strength, lot #, expiration date not provided), administered intramuscularly to prevent human papillomavirus (HPV). On 06-JUN-2018, she was vaccinated with an extra dose of GARDASIL 9 through the same route and for the same indication. On 07-JUN-2018, the patient developed soreness at the site of the last GARDASIL 9 injection (injection site pain), so she sought medical attention by calling a nurse but no treatment was given for the event and no laboratory diagnostic studies were performed. She had not recovered from the event at the time of this report. The causal relationship between the injection site pain and GARDASIL 9 was not provided.
Sore arm, headache, fever up to 102F lasting approximately 48 hours starting about 3 hours post vaccination.
Patient was exposed to a measles outbreak at ER. MMR was given on 4/11/14. On 4/12/14 she had a small cluster of red marks on her chin, cheeks and forehead. The next day more appeared on jaw and chest, she c/o burning at rash site and denied cold s/s or fever. Rash resolved.
pt recvd vax 14JUN94 am-aprpox between 6PM-8PM pt became SOB & loss consiousness-ambulance to ER; wheezing treated w/EPI, IV steroids, Aminophylline, monitored ICU over noc & discharged;
The vaccine had been punctured and at room temperature for 5 days before it was administered (from 9/23/2022 until it was administered on 9/28/2022); No adverse event; The vaccine had been punctured and at room temperature for 5 days before it was administered (from 9/23/2022 until it was administered on 9/28/2022); This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The vaccine had been punctured and at room temperature for 5 days before it was administered (from 9/23/2022 until it was administered on 9/28/2022)), PRODUCT STORAGE ERROR (The vaccine had been punctured and at room temperature for 5 days before it was administered (from 9/23/2022 until it was administered on 9/28/2022)) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 051C22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 28-Sep-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 28-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (The vaccine had been punctured and at room temperature for 5 days before it was administered (from 9/23/2022 until it was administered on 9/28/2022)). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vaccine had been punctured and at room temperature for 5 days before it was administered (from 9/23/2022 until it was administered on 9/28/2022)) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The vaccine had been punctured and at room temperature for 5 days before it was administered (from 9/23/2022 until it was administered on 9/28/2022)), PRODUCT STORAGE ERROR (The vaccine had been punctured and at room temperature for 5 days before it was administered (from 9/23/2022 until it was administered on 9/28/2022)) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (The vaccine had been punctured and at room temperature for 5 days before it was administered (from 9/23/2022 until it was administered on 9/28/2022)) and PRODUCT STORAGE ERROR (The vaccine had been punctured and at room temperature for 5 days before it was administered (from 9/23/2022 until it was administered on 9/28/2022)).    No concomitant medications were provided.  A patient was administered one dose of Spikevax, expiration date 1/13/20123.  The vaccine had been punctured at 23-Sep-2022 and it was administered after 5days at room temperature.  No treatment medications were reported.
During 15 minute observation period, patient complained of dizziness, lightheadedness and minor stomach upset. Patient was instructed to sit down, his feet were elevated, a cold compress was applied. Patient's blood pressure, heart rate and pulse ox were taken.  First blood pressure reading was 168/54 mmHg, first pulse was 71 bpm and pulse ox was 98-99%. Patient was shaky, anxious, and flushed. No complaints of shortness of breath, itching, or swelling of the face/mouth. Repeat vitals after 10 minutes were 185/105 mmHg, pulse was 76 bpm, and pulse ox was 100%. Patient was still dizzy and shaky. Administered 50 mg of diphenhydramine orally and contacted transport to emergency room. While waiting for transport, patient complained of forehead and forearm itching. Still no complaints of shortness of breath, no coughing or lip swelling. Noted red hives starting to appear. EMT arrived and took over care.
Several months after the vaccine, I had an anomaly show up on a mammogram. This may have also been caused by a Shingles Vaccine I received a few weeks before the mammogram. The doctor suspects the anomaly might be a lymph reaction to a vaccine.
Patient was scheduled to receive a flu shot but instead received another dose of the pediatric Pfizer Covid 19 vaccine in error.  First dose was on 11/10/21. No side effects reported.
Experienced pain at the injection site to the point where it required ice. Although ice helped it was very sensitive to the point where if something brushed against my left arm it caused shooting pain. I also experienced extreme fatigue to the point I had to take a nap.
Had a horrible rash her legs opened up in whelps; she really decompensated; Breathing problems; This is a spontaneous report from a contactable consumer (Patient reported for herself). A 58-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, Lot Number: EW0150), via an unspecified route of administration on 05Apr2021 as 2nd dose, single dose for covid-19 immunisation (age at vaccination was 58years). Medical history included Hashimoto's disease, hypopituitarism, Chronic pain, chronic severe calcification tendonitis, cortisol dependent and controlled emphysema. The patient previously took historical vaccine of first dose of bnt162b2 for covid-19 immunisation and experienced trouble Breathing; she took generic for crestor and experienced massive weight gain so she has stopped that now. She was taking CoQ10 to keep the muscle pain down from the statin but it couldn't get rid of it. Concomitant medications included cortisol hydrocortisone [CORTISOL [HYDROCORTISONE]] taken as 12.5 mg when wakes up, 5 mg at 1:00pm, 5 mg at 5:30 pm. Also as needed, when needed, levothyroxine(LEVOTHYROXINE) taken as 88 ug, 1x/day  (88 mcg once a day), metformin taken as 500 mg, 2x/day (twice a day), rosuvastatin calcium (CRESTOR) taken as 5 mg, diphenhydramine hydrochloride (BENADRYL) taken as needed, dhea(DHEA) taken as 5 mg, fish oil, magnesium (MAGNESIUM) taken as 800 mg, daily (800 mg a day), ascorbic acid (VIT C) taken as 100 mg, daily (100 mg a day), acetylcysteine (NAC [ACETYLCYSTEINE]) taken as 600 mg, 1x/day (600mg once a day), Nattokinase taken as 2000 UNK, 1x/day (2000 fu once a day), ubidecarenone (COQ-10) taken as 100 mg, ergocalciferol (VIT D) taken as 4000 iu a day.  The patient reported that 10 minutes after the second shot she had breathing problems and was in the emergency room and then 40 minutes after that, she really decompensated. The caller treated it herself because she kept her inhaler, epi pen, and benadryl on her. She is cortisol dependent and had to take an extra 20mg of cortisol. She also mentioned she had controlled Emphysema. She took her Ventolin inhaler and benadryl after the breathing problems started after the second dose, and then 40 minutes later she was on the road decompensating. The caller did a VSAFE report and gave details then. After the second shot, she had to take benadryl for a few days. After that, she had a horrible rash her legs opened up in whelps. The rash lasted a couple of weeks, it was the entire back of her legs. Whelps were everywhere on her legs, she put hydrocortisone cream on it and it knocked down the itching some. Therapeutic measures were taken as a result of breathing problems and had a horrible rash her legs opened up in whelps. The outcome of the events she really decompensated and breathing problem was unknown, and had a horrible rash her legs opened up in whelps the outcome was recovering.
Slight pain and tenderness the first 24 hours then a mild itching sensation began the following day and through this submission on 2/8/2021. There is no redness or apparent rash, but the injection site is still tender.
On January 29th 2022 patient came to pharmacy asking to receive her first covid vaccine. She chose to receive Moderna, but failed to indicate that she has received the Janssen Covid -19 vaccine  previously in April 2021 at a different location. during my conversation prior to administering the vaccine I inquired as to why the patient had chosen to wait so long to receive her first vaccine. During that conversation, She disclosed to me that she was not comfortable with the vaccines since these are novel vaccines. A little later,  and I had administered the vaccine. On 02/26/2022,  patient returned to receive her second dose of Moderna Vaccine (0.5ml), soon after I administered her second dose, She revealed that she had actually received a dose of Janssen vaccine the year before.  I do not know if patient is or has been experiencing any adverse events from this vaccine. I have made several attempts to reach her by phone and have not been able to get a hold of her. She left soon after getting the vaccines not heeding my advice to remain seated for 15 minutes after the receiving the vaccine.
Redness and swelling around the injection site (it?s hard around the site and itchy). There is no rash anywhere else but I also felt very tired and had a headache the day of and then for most of the following day. I will continue to monitor the symptoms - so far it?s only been 2 days.
Patient became dizzy and diaphoretic at 1210 after her vaccination at 1205. Patient legs elevated and ice pack placed behind neck. Vitals BP 100/60 P 72  T 97.4 and R16.   Water and crackers given.  Patient monitored extra 15 minutes. Patient states feeling better and then released.
About 4 and a half weeks after getting the J&J vaccine, I began to experience marked symptoms: dizziness and disorientation,, balance problems, bilateral numbness in hands, feet and tip of tongue, awareness of left side of brain, intermittent mild nausea (likely related to dizziness).  These symptoms had a sudden onset. I am normally very healthy and active so these unusual symptoms without any illness were quite a departure from my normal health. They have, to date, persisted continually since onset over the past 3 weeks. They are very concerning. Last night I went to the ER to be seen since I could not get an appt. with a neurologist for several months and I am concerned about my sudden change in health status.